Literature DB >> 19395970

Laryngopharyngeal reflux: current concepts and questions.

Reena Gupta1, Robert Thayer Sataloff.   

Abstract

PURPOSE OF REVIEW: Laryngopharyngeal reflux is a widely recognized disorder. Yet, decades after its initial description, debate persists regarding pathophysiology, diagnosis, and treatment. This review addresses current literature on laryngopharyngeal reflux and identifies areas of controversy and future opportunities for research. RECENT
FINDINGS: Despite numerous research efforts, the diagnosis and treatment of laryngopharyngeal reflux remain elusive and unproven. Acid-induced changes in laryngopharyngeal mucosa have been confirmed by histologic evidence. However, the implications of this for laryngeal symptoms and signs are unclear. Diagnosis remains controversial, confounded by lack of standardization and accepted, evidence-based norms. Whereas treatment is generally believed by clinicians to be effective in alleviating symptoms and signs attributed to laryngopharyngeal reflux, incontrovertible data confirming efficacy are scarce. Confounding the issues further, there are numerous studies that purport to show that various widely used treatments are not effective, although the scientific merit of virtually all of these studies has been challenged.
SUMMARY: Laryngopharyngeal reflux remains a controversial diagnosis. Treatment with proton pump inhibitors persists despite weak evidence supporting or refuting their utility, and well designed studies are needed to understand diagnosis, treatment, pathyophysiology, and long-term health consequences of laryngopharyngeal reflux and its treatment.

Mesh:

Substances:

Year:  2009        PMID: 19395970     DOI: 10.1097/MOO.0b013e32832b2581

Source DB:  PubMed          Journal:  Curr Opin Otolaryngol Head Neck Surg        ISSN: 1068-9508            Impact factor:   2.064


  14 in total

1.  Laryngoscopy findings and histological results in a rabbit gastroesophageal reflux model.

Authors:  Ying Hu; Xiao-Bing Xu; Shi-Yao Chen; Hong Gao; Tian-Cheng Luo; Liang Xu; Tian-Yu Zhang
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-03-02       Impact factor: 2.503

Review 2.  [Laryngopharyngeal reflux and larynx-related symptoms].

Authors:  M Ptok; A Ptok
Journal:  HNO       Date:  2012-03       Impact factor: 1.284

Review 3.  Oropharyngeal Reflux Monitoring and Atypical Gastroesophageal Reflux Disease.

Authors:  Dhyanesh A Patel; Ali H Harb; Michael F Vaezi
Journal:  Curr Gastroenterol Rep       Date:  2016-03

Review 4.  Upper aerodigestive tract disorders and gastro-oesophageal reflux disease.

Authors:  Andrea Ciorba; Chiara Bianchini; Michele Zuolo; Carlo Vittorio Feo
Journal:  World J Clin Cases       Date:  2015-02-16       Impact factor: 1.337

5.  Gaviscon® Advance alone versus co-prescription of Gaviscon® Advance and proton pump inhibitors in the treatment of laryngopharyngeal reflux.

Authors:  Mark D Wilkie; Helen M Fraser; Hemal Raja
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-07-30       Impact factor: 2.503

Review 6.  New developments in reflux-associated cough.

Authors:  Jaclyn Smith; Ashley Woodcock; Lesley Houghton
Journal:  Lung       Date:  2009-12-19       Impact factor: 2.584

7.  Does hypopharyngeal-esophageal multichannel intraluminal impedance-pH monitoring for the diagnosis of laryngopharyngeal reflux have to be 24 h?

Authors:  Jinhong Zhang; Xiaoyu Wang; Jiasen Wang; Jing Zhao; Chun Zhang; Zhi Liu; Jinrang Li
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-07-21       Impact factor: 3.236

8.  Esophagogastroduodenoscopy with conscious sedation does not interfere with catheter-based 24-h pH monitoring.

Authors:  Yung-Kuan Tsou; Jau-Min Lien; Chin-Kuo Chen; Cheng-Hui Lin; Hsing-Yu Chen; Mu-Shien Lee
Journal:  World J Gastroenterol       Date:  2013-03-21       Impact factor: 5.742

Review 9.  Voice outcomes of laryngopharyngeal reflux treatment: a systematic review of 1483 patients.

Authors:  Jérôme R Lechien; Camille Finck; Pedro Costa de Araujo; Kathy Huet; Véronique Delvaux; Myriam Piccaluga; Bernard Harmegnies; Sven Saussez
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-03-23       Impact factor: 2.503

10.  Open-Label Observational Study for Evaluating the Short-term Benefits of Rabeprazole Medication on Laryngopharyngeal Reflux.

Authors:  Myung-Hee Shin; Soon Yuhl Nam; Young-Hak Park; Young-Ik Son
Journal:  Clin Exp Otorhinolaryngol       Date:  2012-03-22       Impact factor: 3.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.